Management of myelofibrosis during pregnancy: a case report

Vojnosanit Pregl. 2015 Apr;72(4):383-5. doi: 10.2298/vsp1504383z.

Abstract

Introduction: Primary myelofibrosis (PMF) is a clonal myeloproliferative neoplasm that occurs most commonly in the decade six of life and it is very rare in the young persons.

Case report: We reported a 28-year-old female patient with primary myelofibrosis who had a normal pregnancy and delivery in the week 40 of pregnancy without any complications. Two years before the diagnosis of PMF she had normal pregnancy. The patient was treated with interferon-alpha and low dose aspirin during the whole pregnancy and with low-molecular-weight heparin a week before delivery and 6 weeks after. The patient had no complications during pregnancy. She delivered in term with healthy, normal baby weight.

Conclusion: Decision about treatment strategy of pregnancy associated hematologic malignancies should be made for each patient individually.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aspirin / administration & dosage*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Heparin, Low-Molecular-Weight / administration & dosage*
  • Humans
  • Immunologic Factors / administration & dosage
  • Interferon-alpha / administration & dosage*
  • Pregnancy
  • Pregnancy Complications, Hematologic* / diagnosis
  • Pregnancy Complications, Hematologic* / drug therapy
  • Pregnancy Outcome
  • Primary Myelofibrosis* / diagnosis
  • Primary Myelofibrosis* / drug therapy
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Immunologic Factors
  • Interferon-alpha
  • Aspirin